These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

45 related articles for article (PubMed ID: 17188674)

  • 1. Association of apolipoprotein C3 with insulin resistance and coronary artery calcium in patients with type 1 diabetes.
    Buckner T; Shao B; Eckel RH; Heinecke JW; Bornfeldt KE; Snell-Bergeon J
    J Clin Lipidol; 2021; 15(1):235-242. PubMed ID: 33257283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated apolipoprotein C3 augments diabetic kidney disease and associated atherosclerosis in type 2 diabetes.
    Cervantes J; Koska J; Kramer F; Akilesh S; Alpers CE; Mullick AE; Reaven P; Kanter JE
    JCI Insight; 2024 May; 9(12):. PubMed ID: 38743496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disease activity in patients with rheumatoid arthritis increases serum levels of apolipoprotein C-III.
    Martín-González C; Martín-Folgueras T; Quevedo-Abeledo JC; de Armas-Rillo L; González-Gay MÁ; Ferraz-Amaro I
    Clin Exp Rheumatol; 2023 Jan; 41(1):67-73. PubMed ID: 35383559
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RNA-based therapies targeting APOC3 lower triglyceride levels in patients with hypertriglyceridaemia.
    Huynh K
    Nat Rev Cardiol; 2024 Jun; 21(6):353. PubMed ID: 38654089
    [No Abstract]   [Full Text] [Related]  

  • 5. Functional recombinant apolipoprotein A5 that is stable at high concentrations at physiological pH.
    Castleberry M; Davis X; Liu M; Thompson TB; Tso P; Davidson WS
    J Lipid Res; 2020 Feb; 61(2):244-251. PubMed ID: 31831525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibitors of apolipoprotein C3, triglyceride levels, and risk of pancreatitis: a systematic review and meta-analysis.
    Masson W; Lobo M; Nogueira JP; Corral P; Barbagelata L; Siniawski D
    Rev Endocr Metab Disord; 2024 Jul; ():. PubMed ID: 38997541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting RNA to lower triglycerides: long strides from short molecules.
    Qamar A; Libby P; Bhatt DL
    Eur Heart J; 2019 Sep; 40(33):2797-2800. PubMed ID: 31089714
    [No Abstract]   [Full Text] [Related]  

  • 8. Apolipoprotein C3 and apolipoprotein B colocalize in proximity to macrophages in atherosclerotic lesions in diabetes.
    Kanter JE; Bornfeldt KE
    J Lipid Res; 2021; 62():100010. PubMed ID: 33554869
    [No Abstract]   [Full Text] [Related]  

  • 9. Incidental diagnosis of familial apolipoprotein A5 deficiency.
    Moreno Tirado A; Rodríguez Ortega P; Calle Isorna JM
    Med Clin (Barc); 2024 Apr; ():. PubMed ID: 38692986
    [No Abstract]   [Full Text] [Related]  

  • 10. Apolipoprotein C-III itself stimulates the Syk/cPLA2-induced inflammasome activation of macrophage to boost anti-tumor activity of CD8
    Hu X; Ding S; Lu G; Lin Z; Liao L; Xiao W; Ding Y; Zhang Y; Wang Z; Gong W; Jia X
    Cancer Immunol Immunother; 2023 Dec; 72(12):4123-4144. PubMed ID: 37853273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single-nucleotide polymorphisms as important risk factors of diabetes among Middle East population.
    Akhlaghipour I; Bina AR; Mogharrabi MR; Fanoodi A; Ebrahimian AR; Khojasteh Kaffash S; Babazadeh Baghan A; Khorashadizadeh ME; Taghehchian N; Moghbeli M
    Hum Genomics; 2022 Apr; 16(1):11. PubMed ID: 35366956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Consumption of whole grains and legumes modulates the genetic effect of the APOA5 -1131C variant on changes in triglyceride and apolipoprotein A-V concentrations in patients with impaired fasting glucose or newly diagnosed type 2 diabetes.
    Kang R; Kim M; Chae JS; Lee SH; Lee JH
    Trials; 2014 Apr; 15():100. PubMed ID: 24690159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of apolipoprotein A5 concentration with serum insulin and triglyceride levels and coronary artery disease in Korean men.
    Hyun YJ; Jang Y; Chae JS; Kim JY; Paik JK; Kim SY; Yang JY; Ordovas JM; Ko YG; Lee JH
    Atherosclerosis; 2009 Aug; 205(2):568-73. PubMed ID: 19185864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma apolipoprotein AV levels in mice are positively associated with plasma triglyceride levels.
    Vaessen SF; Dallinga-Thie GM; Ross CJ; Splint LJ; Castellani LW; Rensen PC; Hayden MR; Schaap FG; Kuivenhoven JA
    J Lipid Res; 2009 May; 50(5):880-4. PubMed ID: 19141870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apoprotein A-V: an important regulator of triglyceride metabolism.
    Kluger M; Heeren J; Merkel M
    J Inherit Metab Dis; 2008 Apr; 31(2):281-8. PubMed ID: 18415697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship of apolipoprotein A5 and apolipoprotein C3 levels to serum triglycerides in patients with type 2 diabetes.
    Alborn WE; Prince MJ; Konrad RJ
    Clin Chim Acta; 2007 Mar; 378(1-2):154-8. PubMed ID: 17188674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma apolipoprotein A5 and triglycerides in type 2 diabetes.
    Dallinga-Thie GM; van Tol A; Hattori H; van Vark-van der Zee LC; Jansen H; Sijbrands EJ;
    Diabetologia; 2006 Jul; 49(7):1505-11. PubMed ID: 16752169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apolipoprotein A5 and apolipoprotein C3 single nucleotide polymorphisms are correlated with an increased risk of coronary heart disease: a case-control and meta-analysis study.
    Yang G; Lei MM; Yu CL; Liu XX; An Z; Song CL
    Lipids Health Dis; 2015 Sep; 14():113. PubMed ID: 26387083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of APOA5 and APOC3 gene polymorphisms with plasma apolipoprotein A5 level in patients with metabolic syndrome.
    Niculescu LS; Vlădică M; Sima AV
    Biochem Biophys Res Commun; 2010 Jan; 391(1):587-91. PubMed ID: 19932084
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.